The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype
Open accessAbstract
Identification of specific gene expression signatures characteristic of oncogenic pathways is an important step toward molecular classification of human malignancies. Aberrant activation of the Met signaling pathway is frequently associated with tumor progression and metastasis. In this study, we defined the Met-dependent gene expression signature using global gene expression profiling of WT and Met-deficient primary mouse hepatocytes. Newly identified transcriptional targets of the Met pathway included genes involved in the regulation of oxidative stress responses as well as cell motility, cytoskeletal organization, and angiogenesis. To assess the importance of a Met-regulated gene expression signature, a comparative functional genomic approach was applied to 242 human hepatocellular carcinomas (HCCs) and 7 metastatic liver lesions. Cluster analysis revealed that a subset of human HCCs and all liver metastases shared the Met-induced expression signature. Furthermore, the presence of the Met signature showed significant correlation with increased vascular invasion rate and microvessel density as well as with decreased mean survival time of HCC patients. We conclude that the genetically defined gene expression signatures in combination with comparative functional genomics constitute an attractive paradigm for defining both the function of oncogenic pathways and the clinically relevant subgroups of human cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pfaffl, M. W. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.9.e36 · Cited by 7,376
Cellular Motility Driven by Assembly and Disassembly of Actin Filaments
Pollard, T. D., & Borisy, G. G. (2003) · Cell · doi:10.1016/s0092-8674(03)00120-x · Cited by 4,195
ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
Rhodes, D. R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pander, A., & Chinnaiyan, A. M. (2004) · Neoplasia · doi:10.1016/s1476-5586(04)80047-2 · Cited by 3,612
Michalopoulos, G. K., & DeFrances, M. C. (1997) · Science · doi:10.1126/science.276.5309.60 · Cited by 2,828
Met, metastasis, motility and more
Birchmeier, C., Birchmeier, W., Gherardi, E., & Vande Woude, G. F. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1261 · Cited by 2,602
Nrf2–Keap1 defines a physiologically important stress response mechanism
Motohashi, H., & Yamamoto, M. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.09.003 · Cited by 1,725 · cited 11×
“Itgav Mm.227 Late up 12 h 1.52 2–12 h 2.38 Itga3 Mm.57035 Late up 12 h 1.57 0–24 h 2.21 Adam24 Mm.67403 Early and late up 12 h 2.79 2–12 h 1.70 Fn1 Mm.193099 Late up 24 h 1.52 0–24 h 2.91 Itgb1 Mm.263396 Late up 24 h 1.54 2–12 h 1.71 Stress response Adh1 Mm.2409 Persistent 24 h 0.13 2–12 h 0.49 Aldh1a1A Mm.250866 Pers…”
BackgroundInfluentialIntegrin signalling during tumour progression
Guo, W., & Giancotti, F. G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1490 · Cited by 1,471
Scatter factor/hepatocyte growth factor is essential for liver development
Schmidt, C., Bladt, F., Goedecke, S., Brinkmann, V., Zschiesche, W., Sharpe, M., Gherardi, E., & Birchmeler, C. (1995) · Nature · doi:10.1038/373699a0 · Cited by 1,394
Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud
Bladt, F., Riethmacher, D., Isenmann, S., Aguzzi, A., & Birchmeier, C. (1995) · Nature · doi:10.1038/376768a0 · Cited by 1,284
Rhodes, D. R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pandey, A., & Chinnaiyan, A. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401994101 · Cited by 1,019
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells
Lee, J.-S., Heo, J., Libbrecht, L., Chu, I.-S., Kaposi-Novak, P., Calvisi, D. F., Mikaelyan, A., Roberts, L. R., Demetris, A. J., Sun, Z., et al. (2006) · Nature Medicine · doi:10.1038/nm1377 · Cited by 953
Self-citationClassification and prediction of survival in hepatocellular carcinoma by gene expression profiling
Lee, J.-S., Chu, I.-S., Heo, J., Calvisi, D. F., Sun, Z., Roskams, T., Durnez, A., Demetris, A. J., & Thorgeirsson, S. S. (2004) · Hepatology · doi:10.1002/hep.20375 · Cited by 922
Gene Expression Patterns in Human Liver Cancers
Chen, X., Cheung, S. T., So, S., Fan, S. T., Barry, C., Higgins, J., Lai, K.-M., Ji, J., Dudoit, S., Ng, I. O. L., et al. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.02-02-0023 · Cited by 878
Ye, Q.-H., Qin, L.-X., Forgues, M., He, P., Kim, J. W., Peng, A. C., Simon, R., Li, Y., Robles, A. I., Chen, Y., et al. (2003) · Nature Medicine · doi:10.1038/nm843 · Cited by 850
Lee, J.-M., Calkins, M. J., Chan, K., Kan, Y. W., & Johnson, J. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211558200 · Cited by 786
Huh, C.-G., Factor, V. M., Sánchez, A., Uchida, K., Conner, E. A., & Thorgeirsson, S. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306068101 · Cited by 750
Self-citationHepatocyte growth factor gene therapy of liver cirrhosis in rats
Ueki, T., Kaneda, Y., Tsutsui, H., Nakanishi, K., Sawa, Y., Morishita, R., Matsumoto, K., Nakamura, T., Takahashi, H., Okamoto, E., et al. (1999) · Nature Medicine · doi:10.1038/5593 · Cited by 587
Okabe, H., Satoh, S., Kato, T., Kitahara, O., Yanagawa, R., Yamaoka, Y., Tsunoda, T., Furukawa, Y., & Nakamura, Y. (2001) · PubMed · Cited by 546
Iizuka, N., Oka, M., Yamada-Okabe, H., Nishida, M., Maeda, Y., Mori, N., Takao, T., Tamesa, T., Tangoku, A., Tabuchi, H., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12775-4 · Cited by 511
c-Met: Structure, functions and potential for therapeutic inhibition
Ma, P. C., Maulik, G., Christensen, J., & Salgia, R. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023768811842 · Cited by 504
Integrative analysis of the cancer transcriptome
Rhodes, D. R., & Chinnaiyan, A. M. (2005) · Nature Genetics · doi:10.1038/ng1570 · Cited by 498
Lee, J.-S., Chu, I.-S., Mikaelyan, A., Calvisi, D. F., Heo, J., Reddy, J. K., & Thorgeirsson, S. S. (2004) · Nature Genetics · doi:10.1038/ng1481 · Cited by 475
MacDonald, T. J., Brown, K. M., LaFleur, B., Peterson, K., Lawlor, C., Chen, Y., Packer, R. J., Cogen, P., & Stephan, D. A. (2001) · Nature Genetics · doi:10.1038/ng731 · Cited by 455
The Semaphorin 4D receptor controls invasive growth by coupling with Met
Giordano, S., Corso, S., Conrotto, P., Artigiani, S., Gilestro, G., Barberis, D., Tamagnone, L., & Comoglio, P. M. (2002) · Nature Cell Biology · doi:10.1038/ncb843 · Cited by 444
An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis.
Sweet-Cordero, A., Mukherjee, S., Subramanian, A., You, H., Roix, J. J., Ladd-Acosta, C., Mesirov, J., Golub, T. R., & Jacks, T. (2005) · Nature Genetics · doi:10.1038/ng1490 · Cited by 414
Met receptor tyrosine kinase: enhanced signaling through adapter proteins
Furge, K. A., Zhang, Y.-W., & Vande Woude, G. F. (2000) · Oncogene · doi:10.1038/sj.onc.1203859 · Cited by 410
Hepatocellular Carcinoma: Epidemiology, Risk Factors, and Screening
Sherman, M. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-871194 · Cited by 404
From signatures to models: understanding cancer using microarrays
Segal, E., Friedman, N., Kaminski, N., Regev, A., & Koller, D. (2005) · Nature Genetics · doi:10.1038/ng1561 · Cited by 381
The role of Osteopontin in tumor metastasis
Wai, P. Y., & Kuo, P. C. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2004.03.028 · Cited by 365
Cross-talk between Epidermal Growth Factor Receptor and c-Met Signal Pathways in Transformed Cells*
Jo, M., Stolz, D. B., Esplen, J. E., Dorko, K., Michalopoulos, G. K., & Strom, S. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8806 · Cited by 347
Baron, V, Adamson, E. D., Calogero, A., Ragona, G., & Mercola, D. (2006) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700896 · Cited by 346
Gene expression phenotypic models that predict the activity of oncogenic pathways
Huang, E., Ishida, S., Pittman, J., Dressman, H., Bild, A., Kloos, M., D'Amico, M., Pestell, R. G., West, M., & Nevins, J. R. (2003) · Nature Genetics · doi:10.1038/ng1167 · Cited by 263
Cancer therapy: can the challenge be MET?
Corso, S., Comoglio, P. M., & Giordano, S. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.04.005 · Cited by 238
Ueki, T., Fujimoto, J., Suzuki, T., Yamamoto, H., & Okamoto, E. (1997) · Hepatology · doi:10.1002/hep.510250413 · Cited by 226
Wang, X., DeFrances, M. C., Dai, Y., Pediaditakis, P., Johnson, C., Bell, A., Michalopoulos, G. K., & Zarnegar, R. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00439-2 · Cited by 225
Cellular Motility Driven by Assembly and Disassembly of Actin Filaments
Pollard, T. D., & Borisy, G. G. (2003) · Cell · doi:10.1016/s0092-8674(03)00357-x · Cited by 220
Human CAP1 is a key factor in the recycling of cofilin and actin for rapid actin turnover
Moriyama, K., & Yahara, I. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.8.1591 · Cited by 203
Dhakshinamoorthy, S., & Jaiswal, A. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003531200 · Cited by 203
Human glutamate cysteine ligase gene regulation through the electrophile response element
Dickinson, D. A., Levonen, A.-L., Moellering, D. R., Arnold, E. K., Zhang, H., Darley-Usmar, V. M., & Forman, H. J. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.06.011 · Cited by 196
Merlin and ERM proteins: unappreciated roles in cancer development?
McClatchey, A. I. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1213 · Cited by 191
Epigenetic regulation of gene expression in cervical cancer cells by the tumor microenvironment.
Denko, N. C., Schindler, C., Koong, A. C., Laderoute, K. R., Green, C., & Giaccia, A. J. (2000) · Clinical Cancer Research · Cited by 175
Gerritsen, M. E., Tomlinson, J. E., Zlot, C., Ziman, M., & Hwang, S. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705494 · Cited by 160
(1999) · PubMed · Cited by 158
Park, E. Y., Cho, I. J., & Kim, S. G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3924 · Cited by 145
Fischer, O. M., Giordano, S., Comoglio, P. M., & Ullrich, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402508200 · Cited by 142
Lipschutz, J. H., Li, S., Arisco, A. M., & Balkovetz, D. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408122200 · Cited by 139
Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer
Kinch, M. S., & Carles‐Kinch, K. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1022546620495 · Cited by 136
Schulze‐Bergkamen, H., Brenner, D., Krueger, A., Suess, D., Fas, S. C., Frey, C. R., Dax, A., Zink, D., Büchler, P., Müller, M., et al. (2004) · Hepatology · doi:10.1002/hep.20138 · Cited by 120
Genotype–phenotype relationships in hepatocellular tumors from mice and man†
Stahl, S., Ittrich, C., Marx‐Stoelting, P., Köhle, C., Altug-Teber, Ö., Rieß, O., von Bonin, M., Jobst, J., Kaiser, S., Buchmann, A., et al. (2005) · Hepatology · doi:10.1002/hep.20768 · Cited by 87
Bardelli, A., Basile, M. L., Audero, E., Giordano, S., Wennström, S., Ménard, S., Comoglio, P. M., & Ponzetto, C. (1999) · Oncogene · doi:10.1038/sj.onc.1202607 · Cited by 78
Osteopontin is an autocrine mediator of hepatocyte growth factor-induced invasive growth.
Médico, E., Gentile, A., Celso, C. L., Williams, T. A., Gambarotta, G., Trusolino, L., & Comoglio, P. M. (2001) · PubMed · Cited by 75
Kempiak, S. J., Yamaguchi, H., Sarmiento, C., Sidani, M., Ghosh, M., Eddy, R. J., DesMarais, V. M., Way, M., Condeelis, J. S., & Segall, J. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410713200 · Cited by 70
Matsushima‐Nishiwaki, R., Okuno, M., Takano, Y., Kojima, S., Friedman, S. L., & Moriwaki, H. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg090 · Cited by 67
Strohmeyer, D., Strauss, F., Rössing, C., Roberts, C., Kaufmann, O., Bartsch, G. C., & Effert, P. J. (2004) · PubMed · Cited by 65
Recio, J. A., & Merlino, G. T. (2003) · PubMed · Cited by 63
Reduced Growth Capacity of Hepatocytes from c-myc and c-myc/TGF-α Transgenic Mice in Primary Culture
Kao, C., Factor, V. M., & Thorgeirsson, S. S. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0698 · Cited by 43
Gujdár, A., Sipeki, S., Bander, E., Buday, L., & Faragó, A. (2003) · Cellular Signalling · doi:10.1016/j.cellsig.2003.09.009 · Cited by 8
Cited by
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Calvo, F., Ege, N., Grande-Garcia, A., Hooper, S., Jenkins, R. P., Chaudhry, S. I., Harrington, K., Williamson, P., Moeendarbary, E., Charras, G., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2756 · Cited by 1,478
Genetic landscape and biomarkers of hepatocellular carcinoma
Zucman-Rossi, J., Villanueva, A., Nault, J.-C., & Llovet, J. M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.061 · Cited by 1,325
Hoshida, Y., Nijman, S. M. B., Kobayashi, M., Chan, J. A., Brunet, J.-P., Chiang, D. Y., Villanueva, A., Newell, P., Ikeda, K., Hashimoto, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1089 · Cited by 1,238
Mechanisms of HBV-induced hepatocellular carcinoma
Levrero, M., & Zucman-Rossi, J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.021 · Cited by 1,052
Metadata
- Authors
- Kaposi-Novak, P.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-06-01
- Volume
- 116
- Issue
- 6
- Pages
- 1582-1595
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2042571415
- Cited by
- 398
- References
- 57
- FWCI
- 11.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.